Building sales and marketing in 2023

We are excited to announce the progress that we have made in sales and marketing in 2022. Our team has been working tirelessly to connect with potential customers and showcase our innovative technologies and services.

Through productive discussions with over 60 customers, we have gained valuable insights into their needs and have been able to offer tailored solutions to meet their specific research goals. We are pleased to share that we have signed three contracts for studies in our own lab, which will allow us to showcase our capabilities and provide valuable data to our clients.

In addition, we have received letters of intent from five customers, indicating their strong interest in working with us in the near future. We are committed to delivering high-quality results to all of our clients and are confident that these partnerships will be successful.

Our team has also been active in participating in several conferences throughout the year, including the Drug Discovery Chemistry conference in San Diego, the International Society of Medicinal Chemistry in Nice, the GPCR in Medicinal Chemistry conference in Verona, and the Protein Sciences in Drug Discovery in Cambridge. These conferences have provided us with the opportunity to network with other industry leaders and to stay up-to-date with the latest developments in our field.

To expand our reach and increase accessibility to our services, we have established InSingulo on the commercial research platforms Science Exchange and Scientist.com. We believe that these partnerships will enable us to better connect with researchers across various industries and further grow our business.

In addition to our external efforts, we have also focused on establishing a whole new communications platform and style for our brand. Our new logo, website, and multi-threaded outreach campaign reflect our commitment to innovation and collaboration. We have also published two webinars and two whitepapers that showcase our expertise and thought leadership in the field.

We are proud of the progress we have made in 2022 and are confident that these efforts have set us up for success in 2023. We will continue to prioritize our clients' needs and work towards providing innovative solutions to their research challenges.

As we move forward, we are excited to share more updates with you on how these partnerships develop and the impact they have on our business. Thank you for your continued support and trust in InSingulo.

Previous
Previous

Exploring Challenges and Innovations in GPCR Research with InSingulo

Next
Next

R&D Updates for InSingulo